Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's
Toward development of a safe and effective treatment for Alzheimer's disease, Elan Pharmaceuticals reported a novel γ-secretase inhibitor that specifically targets the cleavage of amyloid-β precursor protein, ...